CLINICA 100 TOP 10: Johnson and Johnson
This article was originally published in Clinica
Executive Summary
Johnson & Johnson may have been quiet on the medtech M&A front recently, doing more streamlining than buying, but it still succeeded in hanging onto the No 1 spot in the Clinica 100 league table*.